<DOC>
	<DOCNO>NCT00004786</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate safety efficacy oral iloprost , prostacyclin analog , patient Raynaud 's phenomenon secondary systemic sclerosis .</brief_summary>
	<brief_title>Phase III Randomized , Double-Blind , Placebo-Controlled Study Oral Iloprost Raynaud 's Phenomenon Secondary Systemic Sclerosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double-blind study . Patients stratify participate institution digital cutaneous ulcer . Patients receive oral iloprost placebo twice daily 6 week . Thrombolytic drug , oral anticoagulant , heparin prohibit study . Concurrent therapy angiotensin-converting enzyme inhibitor Raynaud 's prohibit ; calcium channel blocker severe digital ischemia allow need . Patients follow 2 6 week .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Raynaud Disease</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Raynaud 's phenomenon secondary systemic sclerosis ( SS ) SS meet American College Rheumatology diagnostic criterion At least 6 Raynaud 's attack per week Prior/Concurrent Therapy No prior participation oral iloprost study At least 4 week since participation investigational drug study At least 2 month since prostanoid therapy At least 12 month since sympathectomy upper limb Ongoing therapy systemic sclerosis may continue study Raynaud 's therapy discontinue entry Patient Characteristics Hematopoietic : No platelet disorder Hepatic : No bleed diathesis Renal : Creatinine clearance ( estimate ) least 30 mL/min Cardiovascular : No unstable angina pectoris None follow within 3 month : Stroke Transient ischemic attack Myocardial infarction Other : No active cancer uncontrolled disease No current history alcohol drug abuse No mental disorder preclude compliance No pregnant nursing woman Negative pregnancy test require fertile woman Adequate contraception require fertile woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2001</verification_date>
	<keyword>Raynaud 's syndrome</keyword>
	<keyword>arthritis &amp; connective tissue disease</keyword>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>rare disease</keyword>
	<keyword>systemic sclerosis</keyword>
</DOC>